Is presence of vena caval thrombosis in primary tumor associated with worsened outcomes in metastatic renal cell carcinoma: Analysis of the REMARCC registry

Margaret Meagher(University of California San Diego), Ithaar Derweesh(Rush University Medical Center), Ricardo Autorino(Virginia Commonwealth University Medical Center), Selçuk Erdem(European Association of Urology), Estefanía Linares(Hospital Universitario La Paz), N. Pavan(University of Trieste), M. D’Anna(Hospital Clínic de Barcelona), Michele Marchioni(University of Chieti-Pescara), Andrea Minervini(Azienda Ospedaliero-Universitaria Careggi), Riccardo Campi(University of Florence), M.C. Mir(Fundación Instituto Valenciano de Oncología), M. Kriegmair(Urologische Klinik München), Nail Paksoy, Mireía Musquera(Surgical Specialties (Canada)), Alessandro Antonelli(University of Verona), Francesco Claps(University of Trieste), Giacomo Rebez, E. Rousel(University of California San Diego), Maarten Albersen, Vital Hevia(Hospital Universitario Ramón y Cajal)
European Urology
June 1, 2021
10.1016/s0302-2838(21)01020-4
Cited by 0

Related Papers

Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
|European Urology|2016|1.5k
Intratunical Injection of Human Adipose Tissue–derived Stem Cells Prevents Fibrosis and Is Associated with Improved Erectile Function in a Rat Model of Peyronie's Disease
|European Urology|2012|179
Robot-assisted Kidney Transplantation: The European Experience
|European Urology|2017|143
What Is the Prognostic and Clinical Importance of Urothelial and Nonurothelial Histological Variants of Bladder Cancer in Predicting Oncological Outcomes in Patients with Muscle-invasive and Metastatic Bladder Cancer? A European Association of Urology Muscle Invasive and Metastatic Bladder Cancer Guidelines Panel Systematic Review
|European Urology Oncology|2019|131
Slowdown of urology residents’ learning curve during the COVID‐19 emergency
|British Journal of Urology|2020|130